TTF1 and lung carcinoma: Thus, these data for the first time indicate that TTF-1 promoter-operating distinct miRNA molecule expression also might be an ideal strategy for targeted expression of distinct miRNAs in lung cancer and were helpful for the development of gene therapy against clinical lung cancer.